{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:55:13Z","timestamp":1790996113622,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/brain\/awu020","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T20:25:23Z","timestamp":1393446323000},"page":"1481-1495","source":"Crossref","is-referenced-by-count":305,"title":["Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells"],"prefix":"10.1093","volume":"137","author":[{"given":"Alisdair","family":"McNeill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Magalhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yin","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralyn","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Foltynie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Y.","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.V.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"key\n\t\t\t\t20170425181358_awu020-B1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10545-012-9478-x","article-title":"Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts","volume":"5","author":"Aureli","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t20170425181358_awu020-B3","first-page":"1463","article-title":"Type I Gaucher disease","volume":"170","author":"Balwani","year":"2010","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170425181358_awu020-B4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","article-title":"Ambroxol acts as a pharmacological chaperone for mutant glucocerebrosidase","volume":"50","author":"Bendikov-Bar","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170425181358_awu020-B5","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2009-02-205708","article-title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","volume":"114","author":"Campeau","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170425181358_awu020-B6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.21023","article-title":"Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress","volume":"212","author":"Deganuto","year":"2007","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson\u2019s disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170425181358_awu020-B8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mds.25248","article-title":"The glucocerebrosidase E326K variant predisposes to Parkinson\u2019s disease but does not cause Gaucher\u2019s disease","volume":"28","author":"Duran","year":"2013","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170425181358_awu020-B9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","article-title":"The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease","volume":"80","author":"Gan-Or","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425181358_awu020-B11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0027-5107(01)00232-9","article-title":"Mutation analysis of the beta-glucosidase gene in a patient with type 3 Gaucher disease and neutralizing antibody to alglucerase","volume":"483","author":"Germain","year":"2001","journal-title":"Mut Res"},{"key":"key\n\t\t\t\t20170425181358_awu020-B13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in a-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diabetes.53.2.500","article-title":"Messenger RNA transcripts of the hepatocyte nuclear factor 1-alpha gene containing premature termination codons are subject to nonsense mediated decay","volume":"53","author":"Harries","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170425181358_awu020-B15","first-page":"37","article-title":"Adult Gaucher\u2019s disease: kindred studies and demonstration of a deficiency of acid beta-glucosidase in cultured fibroblasts","volume":"24","author":"Ho","year":"1972","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","article-title":"The genetics and neuropathology of Parkinson\u2019s disease","volume":"124","author":"Houlden","year":"2012","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum Mut"},{"key":"key\n\t\t\t\t20170425181358_awu020-B18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-4159.2012.07879.x","article-title":"Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease","volume":"123","author":"Kurzawa-Akanbi","year":"2012","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425181358_awu020-B19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","article-title":"Tau degradation: the ubiquitin-proteasome system versus the autophagy lysosome system","volume":"105","author":"Lee","year":"2013","journal-title":"Prog Neurobiol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.braindev.2012.05.008","article-title":"The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice","volume":"35","author":"Luan","year":"2013","journal-title":"Brain Dev"},{"key":"key\n\t\t\t\t20170425181358_awu020-B21","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425181358_awu020-B22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and a-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170425181358_awu020-B23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp-2012-302402","article-title":"A clinical and family history study of Parkinson\u2019s disease in glucocerebrosidase mutation carriers","volume":"83","author":"McNeill","year":"2012","journal-title":"J Neurol Neurosurg Psych"},{"key":"key\n\t\t\t\t20170425181358_awu020-B24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0003-9861(78)90274-6","article-title":"Characterization of lysosomal hydrolases that are elevated in Gaucher's disease","volume":"190","author":"Moffitt","year":"1978","journal-title":"Arch Biochem Biophys"},{"key":"key\n\t\t\t\t20170425181358_awu020-B25","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: upregulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170425181358_awu020-B26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicentre study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B27","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","article-title":"Characterization of human glucocerebrosidase from different mutant alleles","volume":"266","author":"Ohashi","year":"1990","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425181358_awu020-B28","doi-asserted-by":"crossref","first-page":"498428","DOI":"10.1155\/2012\/498428","article-title":"Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases","volume":"2012","author":"Otomo","year":"2012","journal-title":"Neurol Res Int"},{"key":"key\n\t\t\t\t20170425181358_awu020-B29","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterisation of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B30","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of parkinsonism in patients with Type I Gaucher disease: data from the IGCC Gaucher registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood Cell Mol Dis"},{"key":"key\n\t\t\t\t20170425181358_awu020-B32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/cb600187q","article-title":"Chemical chaperones and permissive temperatures alter localisation of Gaucher disease associated glucocerebrosidase variants","volume":"1","author":"Sawkar","year":"2006","journal-title":"ACS Chem Biol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","article-title":"Lysosomal storage disorders and Parkinson\u2019s disease: Gaucher disease and beyond","volume":"9","author":"Shachar","year":"2011","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170425181358_awu020-B34","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.1300822110","article-title":"Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease","volume":"110","author":"Schapira","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425181358_awu020-B35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"Settembre","year":"2013","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B36","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425181358_awu020-B37","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425181358_awu020-B38","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/hmg\/ddt052","article-title":"TFEB regulates lysosomal proteostasis","volume":"22","author":"Song","year":"2013","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10238-004-0050-3","article-title":"In vitro and in vivo antioxidant activity of ambroxol","volume":"4","author":"Stetinova","year":"2004","journal-title":"Clin Exp Med"},{"key":"key\n\t\t\t\t20170425181358_awu020-B40","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Nat Acad Sci USA"},{"key":"key\n\t\t\t\t20170425181358_awu020-B41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patient with Type 3 Gaucher Disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170425181358_awu020-B42","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1093\/hmg\/dds367","article-title":"Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in sap-C deficient fibroblasts","volume":"21","author":"Tatti","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1203\/00006450-199805000-00003","article-title":"Genotypic heterogeneity and phenotypic variation among patients with Type 2 Gaucher disease","volume":"43","author":"Tayebi","year":"1998","journal-title":"Ped Res"},{"key":"key\n\t\t\t\t20170425181358_awu020-B44","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","article-title":"GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology","volume":"79","author":"Tsuang","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425181358_awu020-B45","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","article-title":"Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease","volume":"19","author":"Vitner","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/hmg\/ddm324","article-title":"ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones","volume":"17","author":"Wei","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425181358_awu020-B47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type I Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells Mol Dis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/137\/5\/1481\/13797138\/awu020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T17:49:08Z","timestamp":1648403348000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awu020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,2,25]]},"published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awu020","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}